NVIDIA Corporation (NVDA) — closed signal from July 2, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on September 30, 2026 — +15.2% at the close.
Predicted vs. what happened
What happened
Reached its target in 64 days.
The thesis — published July 2, 2026
NVIDIA is the clear leader in chips and software used for AI, gaming, and data centers, with very strong profits and cash on hand. Near-term timing is uncertain because recent market talk warns investors are stepping back from AI stocks and the price momentum hasn't recovered. If the market calms, the stock could rebound, but high valuation and many competitors keep it on Watch.
Primary drivers
- Industry-leading chips and AI software that drive demand
- Large cash reserves and low debt support stability
- Recent price decline creates a more attractive risk/reward
- Wider sector cooling limits near-term upside potential
How it played out
NVDA: target reached in 64 days
Lyra published the NVDA thesis at $198.26, with expected growth of 18% and a target of $233.94. The thesis pointed to leading chips and software for artificial intelligence, gaming and data centers, along with large cash reserves, low debt and a recent price decline. It also cited sector cooling as a limit on near-term upside.
NVDA reached a peak of $234.50 on September 4, a gain of 18.3%. It reached the target in 64 days, then ended the window at $228.38. The published thesis played out, although the stock finished below the target.
What happened during the window
On August 26, 2026, NVIDIA reported second-quarter revenue of $96.2 billion and data center revenue of $89.0 billion. On September 28, 2026, the company announced a $150 billion increase to its share repurchase authorization.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.